10.07.2015 Views

Cornea - ARVO

Cornea - ARVO

Cornea - ARVO

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

<strong>ARVO</strong> 2013 Annual Meeting Abstracts by Scientific Section/Group - <strong>Cornea</strong>medication known to affect tear production. Subjects were evaluatedat three visits, including the initial screening, at intervals ofapproximately two weeks over the course of approximately 30 days.Research was conducted in compliance with the Declaration ofHelsinki, all subjects completed informed consent prior to the study.Results: Tear osmolarity (316.9±6.2 to 304.8±16.0, p = 0.039),conjunctival staining (1.6±0.8 to 0.7±0.8, p=0.027), symptomfrequency (4.8±2.2 to 2.0±1.5, p=0.004) and symptom severity(5.1±1.2 to 1.9±1.4, p

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!